321 related articles for article (PubMed ID: 15809156)
1. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
3. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
4. Triple helix-forming oligonucleotides conjugated to new inhibitors of topoisomerase II: synthesis and binding properties.
Duca M; Oussedik K; Ceccaldi A; Halby L; Guianvarc'h D; Dauzonne D; Monneret C; Sun JS; Arimondo PB
Bioconjug Chem; 2005; 16(4):873-84. PubMed ID: 16029029
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a triplex-forming oligonucleotide-pyrrolobenzodiazepine conjugate.
Zhilina ZV; Ziemba AJ; Trent JO; Reed MW; Gorn V; Zhou Q; Duan W; Hurley L; Ebbinghaus SW
Bioconjug Chem; 2004; 15(6):1182-92. PubMed ID: 15546183
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV-1 activity by a triple-helix forming oligonucleotides targeted to polypurine tract on viral RNA.
Hiratou T; Tsukahara S; Miyano-Kurosaki N; Takai K; Saito T; Yamamoto N; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1721-34. PubMed ID: 11200268
[TBL] [Abstract][Full Text] [Related]
7. Head-to-head bis-hairpin polyamide minor groove binders and their conjugates with triplex-forming oligonucleotides: studies of interaction with target double-stranded DNA.
Halby L; Ryabinin VA; Sinyakov AN; Novopashina DS; Venyaminova AG; Grokhovsky SL; Surovaya AN; Gursky GV; Boutorine AS
J Biomol Struct Dyn; 2007 Aug; 25(1):61-76. PubMed ID: 17676939
[TBL] [Abstract][Full Text] [Related]
8. New TFO conjugates containing a carminomycinone-derived chromophore.
Capobianco ML; De Champdoré M; Francini L; Lena S; Garbesi A; Arcamone F
Bioconjug Chem; 2001; 12(4):523-8. PubMed ID: 11459456
[TBL] [Abstract][Full Text] [Related]
9. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of in vitro transcription elongation by triplex-forming oligonucleotide-intercalator conjugates targeted to HIV proviral DNA.
Giovannangeli C; Perrouault L; Escudé C; Nguyen T; Hélène C
Biochemistry; 1996 Aug; 35(32):10539-48. PubMed ID: 8756710
[TBL] [Abstract][Full Text] [Related]
11. Modulation of psoralen DNA crosslinking kinetics associated with a triplex-forming oligonucleotide.
Oh DH; Suzara V; Krishnan R
Photochem Photobiol; 2008; 84(3):727-33. PubMed ID: 18435621
[TBL] [Abstract][Full Text] [Related]
12. Triple helix formation by (G,A)-containing oligonucleotides: asymmetric sequence effect.
Arimondo PB; Barcelo F; Sun JS; Maurizot JC; Garestier T; Hélène C
Biochemistry; 1998 Nov; 37(47):16627-35. PubMed ID: 9843430
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 replication by foldback triple-helix forming oligonucleotides.
Hiratou T; Tsukahara S; Takai K; Koyanagi Y; Yamamoto N; Takaku H
Nucleic Acids Symp Ser; 1997; (37):221-2. PubMed ID: 9586079
[TBL] [Abstract][Full Text] [Related]
14. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment.
Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C
Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289
[TBL] [Abstract][Full Text] [Related]
15. Targeting MDR1 gene: synthesis and cellular study of modified daunomycin-triplex-forming oligonucleotide conjugates able to inhibit gene expression in resistant cell lines.
Stierlé V; Duca M; Halby L; Senamaud-Beaufort C; Capobianco ML; Laigle A; Jollès B; Arimondo PB
Mol Pharmacol; 2008 May; 73(5):1568-77. PubMed ID: 18299310
[TBL] [Abstract][Full Text] [Related]
16. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells.
Faria M; Wood CD; White MR; Hélène C; Giovannangeli C
J Mol Biol; 2001 Feb; 306(1):15-24. PubMed ID: 11178890
[TBL] [Abstract][Full Text] [Related]
17. Comparison of triple helix formation by polypurine versus polypyrimidine oligodeoxynucleotides when conjugated to a DNA intercalator.
Orson FM; Klysik J; Glass GA; Kinsey BM
J Exp Ther Oncol; 1996 May; 1(3):177-85. PubMed ID: 9414402
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and triplex-forming properties of 2',4'-BNA derivatives bearing pyridines as an unnatural nucleobase.
Matsugu S; Inohara H; Obika S; Imanishi T
Nucleic Acids Symp Ser (Oxf); 2005; (49):159-60. PubMed ID: 17150682
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the sequence of twisted intercalating nucleic acids (TINA) forming triple helix with the polypurine tract of the proviral HIV DNA.
Boutorine AS; Doluca O; Filichev VV
Nucleic Acids Symp Ser (Oxf); 2009; (53):139-40. PubMed ID: 19749299
[TBL] [Abstract][Full Text] [Related]
20. Highly stable DNA triplexes formed with cationic phosphoramidate pyrimidine alpha-oligonucleotides.
Michel T; Debart F; Heitz F; Vasseur JJ
Chembiochem; 2005 Jul; 6(7):1254-62. PubMed ID: 15912553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
